Evidence map›Paper›PMID 22623650›Full record

ArticleClinical and vaccine immunology : CVI2012

Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells.

Jill E Roughan, Kathryn M Reardon, Kristin E Cogburn, Heribert Quendler, Paul J Pockros, Mansun Law

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Autoimmunity and infection in Sjögren's syndrome.Current opinion in rheumatology · 2013
    Review
  10. Immunity and hepatitis C: a review.Current HIV/AIDS reports · 2013
    Review
  11. Review
  12. Hepatitis C virus infection and autoimmune diseases.International journal of general medicine · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jill E RoughanDepartment of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, USA.
Kathryn M Reardon
Kristin E Cogburn
Heribert Quendler
Paul J Pockros
Mansun Law
Scripps Research Institute · USScripps Health · US

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
PATHOGENESIS AND IMMUNOLOGY OF DISEASET32AI007244 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1985 to 2022
$8.8M
Understanding human neutralizing antibodies to hepatitis C virusR01AI079031 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI LAW, MANSUN · 2008 to 2017
$4.6M
Probing the antibody response to HCV to facilitate rational immunogen designR01AI071084 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI BURTON, DENNIS R. · 2009 to 2013
$3.1M
Hepatitis C virus E2 glycoproteinR21AI080916 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI LAW, MANSUN · 2009 to 2010
$522k
NIAID NIH HHS AI71084NIAID NIH HHS AI79031NIAID NIH HHS AI80916NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI071084NIAID NIH HHS R01 AI079031NIAID NIH HHS R21 AI080916NIAID NIH HHS T32 AI007244PHS HHS T32 A1007244-28
6 · The paper itself

Abstract

Chronic Hepatitis C virus (HCV) infection has been linked with B cell lymphoproliferative disorders and several autoimmune-related diseases. The mechanisms of how chronic viral infection affects B cell development and predisposes the patients to autoimmune manifestations are poorly understood. In this study, we established an experimental system to probe the B cell responses and characterize the antibodies from chronic-HCV-infected individuals. We identified an unusual polyclonal expansion of the IgM memory B cell subset in some patients. This B cell subset is known to be tightly regulated, and autoreactive cells are eliminated by tolerance mechanisms. Genetic analysis of the immunoglobulin (Ig) heavy chain variable gene (V(H)) sequences of the expanded cell population showed that the levels of somatic hypermutation (SHM) correlate with the extent of cell expansion in the patients and that the V(H) genes exhibit signs of antigen-mediated selection. Functional analysis of the cloned B cell receptors demonstrated autoreactivity in some of the expanded IgM memory B cells in the patients which is not found in healthy donors. In summary, this study demonstrated that, in some patients, chronic HCV infection disrupts the tolerance mechanism that normally deletes autoreactive B cells, therefore increasing the risk of developing autoimmune antibodies. Long-term follow-up of this expanded B cell subset within the infected individuals will help determine whether these cells are predictors of more-serious clinical manifestations.

Indexed as

Immune ToleranceAdultAgedAutoantibodiesAutoimmune DiseasesB-LymphocytesB-Lymphocyte SubsetsFemaleHepatitis C, ChronicHumansImmunoglobulin GImmunoglobulin Heavy ChainsImmunoglobulin MImmunoglobulin Variable RegionImmunologic MemoryMaleAutoantibodiesImmunoglobulin GImmunoglobulin Heavy ChainsImmunoglobulin MImmunoglobulin Variable Region

Identifiers

PMID22623650
PMCPMC3393369
OpenAlexW2126841260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.